Related Experiment Video

Updated: May 19, 2026

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity
09:32

Drug-Induced Senescence in Liver Cells Promotes M2 Macrophage Polarization: Implications for Tyrosine Kinase Inhibitor-Associated Hepatotoxicity

Published on: October 17, 2025

LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear

Fei-hong Chen1, Na Lu, Hai-wei Zhang

  • 1State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, Nanjing, China.

Molecular Pharmacology
|August 23, 2012
PubMed

Insights

LYG-202 enhances tumor necrosis factor-α (TNF-α) cancer treatment by inhibiting casein kinase 2 (CK2) and the NF-κB pathway. This combination therapy boosts apoptosis and antineoplastic effects in solid tumors.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pharmacology

Background:

  • Tumor necrosis factor-α (TNF-α) is an antineoplastic agent with limited activity alone.
  • Combination therapies are crucial for enhancing TNF-α's efficacy in treating solid tumors.
  • LYG-202, a novel flavonoid, exhibits antiproliferative, antiangiogenic, and proapoptotic properties.

Purpose of the Study:

  • To evaluate the antineoplastic effect of combining TNF-α with LYG-202.
  • To elucidate the underlying molecular mechanisms of this combination therapy.
  • To investigate LYG-202's potential as a casein kinase 2 (CK2) inhibitor.

Main Methods:

  • In vitro studies using HepG2 cells to assess cytostatic and proapoptotic activities.
  • Kinase activity assays to determine LYG-202's effect on CK2.
  • Electrophoretic mobility shift and luciferase assays to analyze NF-κB signaling.
  • Murine xenograft models to evaluate in vivo efficacy.

Main Results:

  • LYG-202 significantly enhanced TNF-α's cytostatic and proapoptotic effects in HepG2 cells.
  • LYG-202 demonstrated significant inhibition of CK2 activity.
  • LYG-202 blocked TNF-α-induced NF-κB survival signaling by inactivating CK2.
  • In vivo studies confirmed enhanced antineoplastic activity and inhibition of CK2/NF-κB pathway.

Conclusions:

  • LYG-202 potentiates TNF-α-induced apoptosis by inhibiting the CK2-dependent NF-κB pathway.
  • LYG-202 is a promising agent for combination therapy with TNF-α in cancer treatment.
  • The findings suggest a novel therapeutic strategy targeting CK2 and NF-κB signaling.

Related Concept Videos

The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...